Poster Presentations
Pharmacokinetics and transcriptomic analysis reveal the molecular signature of mucosal healing in patients with Acute Severe Ulcerative Colitis treated with infliximab (PROTOS)
Poster Presentation
Session Information
Session: Genetics, Epigenetics, and Gene Function in IBD
Presenter: Dr. Robert Battat
Date: May 2, 2026
Time: 12:30–1:30 PM CDT
Session Hall: Poster Hall, Level 3, Hall F2
Evaluation of transmural healing in patients with moderately to severely active Crohn’s disease shows early efficacy of vedolizumab: VECTORS week 14 interim analysis
Poster Presentation
Session Information
Session: Controlled Clinical Trials of IBD Treatment
Presenter: Dr. Vipul Jairath
Date: May 4, 2026
Time: 12:30–1:30 PM CDT
Session Hall: Poster Hall, Level 3, Hall F2
Molecular and cellular signatures accompanying early disease clearance in Ulcerative Colitis patients treated with vedolizumab in the VERDICT trial
Poster Presentation
Session Information
Session: Omics, Spatial and Systems Biology I
Presenter: Dr. Saurabh Mehandru
Date: May 4, 2026
Time: 12:30–1:30 PM CDT
Session Hall: Poster Hall, Level 3, Hall F2
Schedule a Meeting
Fields marked with * are required.